Literature DB >> 454262

Cryopexy treatment of proliferative diabetic retinopathy. Retinal cryoablation in patients with severe vitreous hemorrhage.

R A Schimek, R Spencer.   

Abstract

Severe diabetic retinopathy with neovascular proliferation may produce severe vitreous hemorrhage that prevents laser therapy. Retinal ablation, if indicated, can be partly accomplished by cryopexy. In a small series of cases, cryotherapy to the retina was not apparently harmful and sometimes seemed beneficial. Blood absorption seemed more rapid and recurrent bleeding less frequent; however, vitreous hemorrhages in proliferative diabetic retinopathy are too variable in their natural history of absorption and recurrence to permit any definite conclusion as to the value of this method of retinal ablation. A national collaborative study with lengthy follow-ups will be necessary to determine whether chorioretinal scars produced by laser therapy and those produced by cryotherapy will afford similar protection from the forward course of proliferative diabetic retinopathy, vitreous hemorrhage and blindness. In the meantime, this report is intended to alert ophthalmologists that retinal cryoablation is a conservation alternative to "early" vitrectomy for vitreous hemorrhages from diabetic retinopathy.

Entities:  

Mesh:

Year:  1979        PMID: 454262     DOI: 10.1001/archopht.1979.01020020018004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  G W Blankenship
Journal:  Trans Am Ophthalmol Soc       Date:  1987

2.  Contact transscleral retinopexy using a sapphire crystal probe.

Authors:  H D Schubert; C W Talbot; J L Federman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Postvitrectomy hypotonia: the role of the vitreous and retinochoroidal lesions.

Authors:  H D Schubert; K Kuang; J Fischbarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

4.  External diathermy treatment of proliferative diabetic retinopathy with vitreous haemorrhage.

Authors:  A L Siam
Journal:  Br J Ophthalmol       Date:  1986-02       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.